Vital Therapies' IPO

Vital Therapies raised a round of funding on April 17, 2014. Investors include Public.

Vital Therapies is a development-stage biotechnology company developing ELAD, an extracorporeal liver support system which functions by processing toxins and synthesizing proteins and metabolites that…

Articles about Vital Therapies' IPO: